Health Affairs December 7, 2022
Henry A. Waxman

It has been 30 years since the 340B drug pricing program became law. 340B is one of a series of policies that those of us serving in Congress at the time adopted to address the need for a robust health care safety net to serve patients with low incomes throughout the country.

Two years prior to 340B’s enactment, we approved legislation to reduce payments for drugs under the state-federal partnership known as Medicaid. While the new law reined in Medicaid costs, many of us were concerned that it also had the unintended consequence of increasing costs for providers who served large numbers of patients living with low incomes.

Congress created 340B to address this concern and to provide resources for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Health System / Hospital, HHS, Insurance, Medicaid, Medicare, Pharma, Pharma / Biotech, Provider
Achieving Value-Based Care Through the Payvider Model
Epic's new interoperability push, explained
How 3 Health Systems Are Scaling Hybrid & Home-Based Models
CMS finalizes new kidney transplant model: 10 things to know
How Providers Are Turning The Home Into A Hospital

Share This Article